Search Results - "Cho, Song Hye"
-
1
MEDI3726, a prostate-specific membrane antigen (PSMA)-targeted antibody-drug conjugate (ADC) in mCRPC after failure of abiraterone or enzalutamide
Published in Journal of clinical oncology (20-02-2020)“…Abstract only 99 Background: MEDI3726 is an ADC targeting PSMA. Once bound to PSMA and internalized, the released pyrrolobenzodiazepine dimer toxin crosslinks…”
Get full text
Journal Article -
2
A phase 1/1b multicenter, open-label, dose escalation and dose expansion study to evaluate the safety, pharmacokinetics, immunogenicity, and antitumor activity of MEDI3726 in patients with metastatic, castration-resistant prostate cancer who have received prior treatment with abiraterone or enzalutamide
Published in Journal of clinical oncology (20-05-2017)“…Abstract only TPS5088 Background: Therapeutic advances have recently been achieved for patients with metastatic, castration-resistant prostate cancer (mCRPC)…”
Get full text
Journal Article -
3
Participation of bcl-2 and bax in epidermal homeostasis and non-melanoma skin cancer
Get full text
Dissertation -
4
Participation of bcl -2 and bax in epidermal homeostasis and non-melanoma skin cancer
Published 01-01-2001“…Non-melanoma skin cancer (NMSC) is the most frequently diagnosed form of cancer in United States. As in many other cancers, this slow growing malignancy…”
Get full text
Dissertation